Orion Portfolio Solutions LLC cut its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 11.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,444 shares of the health services provider’s stock after selling 1,792 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Maximus were worth $1,252,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of MMS. Cetera Advisors LLC bought a new position in shares of Maximus during the first quarter valued at $235,000. SG Americas Securities LLC boosted its position in shares of Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after buying an additional 12,266 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Maximus by 4.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock valued at $272,000 after buying an additional 136 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after buying an additional 262 shares during the last quarter. Finally, Raymond James & Associates boosted its position in shares of Maximus by 9.6% during the second quarter. Raymond James & Associates now owns 14,516 shares of the health services provider’s stock valued at $1,244,000 after buying an additional 1,275 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director Raymond B. Ruddy bought 3,490 shares of the company’s stock in a transaction on Thursday, December 12th. The shares were acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the completion of the transaction, the director now owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now directly owns 6,567 shares in the company, valued at $607,841.52. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.40% of the company’s stock.
Maximus Trading Down 1.3 %
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were given a $0.30 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.72%. Maximus’s payout ratio is 24.00%.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.
View Our Latest Stock Report on MMS
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- Want to Profit on the Downtrend? Downtrends, Explained.
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Basic Materials Stocks Investing
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Investing in the High PE Growth Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.